City

Bethesda (1)

Condition

PET Positive (1)

Prostate Cancer (1)

Recurrent Prostate Cancer (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

National Cancer Institute (NCI) (1)

Collaborator

Intervention

enzalutamide (1)

m9241 (1)

Study Documents

Intervention Type

drug (1)

Funder Type

NIH (1)

Study Type

Interventional (1)

pet positive

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Prostate Cancer, Recurrent Prostate Cancer, PET Positive Trial run by the National Cancer Institute (NCI) (Enzalutamide, M9241)

Not yet recruiting

Prostate Cancer
+2 more

Bethesda, Maryland

National Institutes of Health Clinical Center

Oct 27, 2023